The National Guidelines on Automated Medication Management Systems 2021 has been developed by the National Automated Medication Management Systems Taskforce (NAMMST) under the National Medication Safety Committee (NMSC) 2017-2021 term.
This document is a national guideline developed by the National Automated Medication Management Systems Taskforce under the National Medication Safety Committee. It is intended as a reference guide for healthcare institutions that plan to implement a new automated medication management system or review an existing one.
The guideline covers project management, including selection, procurement, pre-implementation, implementation, and post-implementation, as well as operation of automated medication management systems, including raw-material selection, production, quality control, handling of non-conforming outputs, and line clearance.
An AMMS is a computerised drug repackaging or storage device/machine that allows medications to be repackaged, stored, and/or dispensed in healthcare settings.
They serve as a reference guide for any healthcare institution with the intention to implement a new AMMS or review its existing AMMS.
The covered system-system interactions are limited to AMMS software to clinical systems.